Reuters logo
BRIEF-Emergent Biosolutions announces preliminary 2016 financial results
January 9, 2017 / 12:24 PM / 9 months ago

BRIEF-Emergent Biosolutions announces preliminary 2016 financial results

Jan 9 (Reuters) - Emergent Biosolutions Inc

* Emergent Biosolutions announces preliminary 2016 financial results and provides 2017 financial outlook

* Sees Q1 2017 revenue $120 million to $135 million

* Sees FY 2016 revenue $500 million to $505 million

* Emergent Biosolutions sees 2017 total revenue $500 million - $530 million; 2017 net income $60 million- $70 million; 2017 biothrax sales $265 million - $280 million

* For full year 2016, company anticipates cash and cash equivalents at year end of approximately $270 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below